R. E. Warren
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Pneumonia and Respiratory Infections 2
- Fungal Infections and Studies 2
-
- Antifungal resistance and susceptibility 3
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- David Edwards (1 shared paper)F.K. Gould (1 shared paper)A.P. Fraise (1 shared paper)G L Ridgway (1 shared paper)C. G. Gemmell (1 shared paper)Neil Woodford (4 shared papers)David M. Livermore (2 shared papers)M. Warner (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (9 papers)Journal of Clinical Pathology (3 papers)Journal of Medical Microbiology (2 papers)Clinical Microbiology and Infection (1 paper)Journal of Infection (1 paper)
- Partner nations
- United KingdomMaldivesSwitzerland
In The Last Decade
R. E. Warren
20 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Molecular Medicine 595
- Applied Microbiology and Biotechnology 80
- Endocrinology 214
- Clinical Biochemistry 170
- Infectious Diseases 375
Countries citing papers authored by R. E. Warren
This map shows the geographic impact of R. E. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Warren more than expected).
Fields of papers citing papers by R. E. Warren
This network shows the impact of papers produced by R. E. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Warren. The network helps show where R. E. Warren may publish in the future.
Co-authors
The 25 scholars most cited alongside R. E. Warren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 414 | |
| 2 | 2006 | 327 | |
| 3 | 1997 | 126 | |
| 4 | 2008 | 99 | |
| 5 | 2010 | 88 | |
| 6 | 2008 | 66 | |
| 7 | 2008 | 51 | |
| 8 | 2008 | 30 | |
| 9 | 1985 | 21 | |
| 10 | 2002 | 20 | |
| 11 | 1992 | 18 | |
| 12 | 2009 | 16 | |
| 13 | 1995 | 16 | |
| 14 | 2008 | 13 | |
| 15 | 1996 | 8 | |
| 16 | 1993 | 5 | |
| 17 | 1999 | 5 | |
| 18 | 1988 | 2 | |
| 19 | Antimicrobial-Resistant Pathogens in Animals and Man: Prescribing, Practices and Policies. A Joint Meeting Between Medical and Veterinary Specialists on Antibiotic Resistance and Antibiotic Use, London, UK, February 2009. | 2010 | 1 |
| 20 | 1982 | 1 |
About R. E. Warren
R. E. Warren is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Clinical Biochemistry and Microbiology, having authored 20 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Antifungal resistance and susceptibility (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Infections and Vaccines (2 papers), Pneumonia and Respiratory Infections (2 papers), Fungal Infections and Studies (2 papers) and Infectious Diseases and Tuberculosis (2 papers). The work is most often cited by research in Molecular Medicine (595 citations), Applied Microbiology and Biotechnology (80 citations), Endocrinology (214 citations), Clinical Biochemistry (170 citations) and Infectious Diseases (375 citations). R. E. Warren has collaborated with scholars based in United Kingdom, Maldives and Switzerland. Frequent co-authors include David Edwards, F.K. Gould, A.P. Fraise, G L Ridgway, C. G. Gemmell, Neil Woodford, David M. Livermore, M. Warner, Deborah James and Rachel Pike. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Clinical Pathology, Journal of Medical Microbiology, Clinical Microbiology and Infection and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.